Chemoprevention of Melanoma

Advances in Pharmacology

Volumn 65, Issue , 2012, Pages 361-398

  Madhunapantula, SubbaRao V ^a   Robertson, Gavin P ^b,c  

^a JSS MEDICAL COLLEGE   (India)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Chemopreventive agents; Melanoma; Resveratrol; Selenium; Statins; Sunscreen

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; 8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE; ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; BERBERINE; BETA CAROTENE; BETULIC ACID; CELECOXIB; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; DACARBAZINE; EFLORNITHINE; EPIGALLOCATECHIN GALLATE; FLUOROURACIL; HEXAHYDROXYSTILBENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; POLYCYTIDYLIC ACID; RESVERATROL; SELENIUM; SELENOMETHIONINE; SILYMARIN; SOYBEAN PROTEIN; SUNSCREEN; TILORONE; UNCLASSIFIED DRUG; VEMURAFENIB; VITAMIN D;

ACTINIC KERATOSIS; ARTICLE; BREAST CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG STRUCTURE; HEAD AND NECK CARCINOMA; HUMAN; LOW DRUG DOSE; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MELANOMA; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION EXPOSURE; SKIN CANCER; UTERINE CERVIX CANCER;

EID: 84865858344     PISSN: 10543589     EISSN: 15578925     Source Type: Book Series    
DOI: 10.1016/B978-0-12-397927-8.00012-9     Document Type: Chapter

References (199)

1. Abdel-Malek Z.A., Kadekaro A.L., Swope V.B. Stepping up melanocytes to the challenge of UV exposure. Pigment Cell & Melanoma Research 2010, 23:171-186.
2. Afaq F., Adhami V.M., Mukhtar H. Photochemoprevention of ultraviolet B signaling and photocarcinogenesis. Mutation Research 2005, 571:153-173.
3. Afaq F., Katiyar S.K. Polyphenols: skin photoprotection and inhibition of photocarcinogenesis. Mini Reviews in Medicinal Chemistry 2011, 11:1200-1215.
4. Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Research 2004, 24:2783-2840.
5. Allen N.E., Appleby P.N., Roddam A.W., Tjonneland A., Johnsen N.F., Overvad K., et al. Plasma selenium concentration and prostate cancer risk: results from the European prospective investigation into cancer and nutrition (EPIC). The American Journal of Clinical Nutrition 2008, 88:1567-1575.
6. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: an " old-age" disease with an " age-old" solution. Cancer Letters 2008, 267:133-164.
7. Anand P., Thomas S.G., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Sung B., et al. Biological activities of curcumin and its analogues (congeners) made by man and mother nature. Biochemical Pharmacology 2008, 76:1590-1611.
8. Antoniou C., Kosmadaki M.G., Stratigos A.J., Katsambas A.D. Sunscreens - what's important to know. Journal of the European Academy of Dermatology and Venereology: JEADV 2008, 22:1110-1118.
9. Armstrong W.B., Taylor T.H., Meyskens F.L. Point: surrogate end point biomarkers are likely to be limited in their usefulness in the development of cancer chemoprevention agents against sporadic cancers. Cancer Epidemiology, Biomarkers & Prevention 2003, 12:589-592.
10. Asgari M.M., Maruti S.S., White E. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence. Journal of the National Cancer Institute 2008, 100:967-971.
11. Autier P., Dore J.F., Schifflers E., Cesarini J.P., Bollaerts A., Koelmel K.F., et al. Melanoma and use of sunscreens: an Eortc case-control study in Germany, Belgium and France. The EORTC melanoma cooperative group. International Journal of Cancer 1995, 61:749-755.
12. Autier P., Dore J.F., Eggermont A.M., Coebergh J.W. Epidemiological evidence that UVA radiation is involved in the genesis of cutaneous melanoma. Current Opinion in Oncology 2011, 23:189-196.
13. Aziz M.H., Afaq F., Ahmad N. Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin. Photochemistry and Photobiology 2005, 81:25-31.
14. Aziz M.H., Reagan-Shaw S., Wu J., Longley B.J., Ahmad N. Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?. FASEB Journal 2005, 19:1193-1195.
15. Azizi E., Iscovich J., Pavlotsky F., Shafir R., Luria I., Federenko L., et al. Use of sunscreen is linked with elevated naevi counts in Israeli school children and adolescents. Melanoma Research 2000, 10:491-498.
16. Back J.H., Zhu Y., Calabro A., Queenan C., Kim A.S., Arbesman J., et al. Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis(dagger). Photochemistry and Photobiology 2012.
17. Balch C.M., Buzaid A.C., Soong S.J., Atkins M.B., Cascinelli N., Coit D.G., et al. Final version of the American joint committee on cancer staging system for cutaneous melanoma. Journal of Clinical Oncology 2001, 19:3635-3648.
18. Baliga M.S., Katiyar S.K. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochemical & Photobiological Sciences 2006, 5:243-253.
19. Banerji A., Chakrabarti J., Mitra A., Chatterjee A. Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells. Cancer Letters 2004, 211:235-242.
20. Bard S., Kirsner R.S. Do nonsteroidal anti-inflammatory drugs prevent melanoma?. The Journal of Investigative Dermatology 2011, 131:1394.
21. Barthelman M., Bair W.B., Stickland K.K., Chen W., Timmermann B.N., Valcic S., et al. (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis 1998, 19:2201-2204.
22. Barton M.K. Sunscreen use in adults is beneficial in preventing melanoma. CA: A Cancer Journal for Clinicians 2011, 61:137-138.
23. Becker M.R., Siegelin M.D., Rompel R., Enk A.H., Gaiser T. COX-2 expression in malignant melanoma: a novel prognostic marker?. Melanoma Research 2009, 19:8-16.
24. Becker J.C., Houben R., Schrama D., Voigt H., Ugurel S., Reisfeld R.A. Mouse models for melanoma: a personal perspective. Experimental Dermatology 2010, 19:157-164.
25. Bennett D.C. How to make a melanoma: what do we know of the primary clonal events?. Pigment Cell & Melanoma Research 2008, 21:27-38.
26. Bennett D.C. Ultraviolet wavebands and melanoma initiation. Pigment Cell & Melanoma Research 2008, 21:520-524.
27. Bhat K.P., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Annals of the New York Academy of Sciences 2002, 957:210-229.
28. Bodzioch M., Dembinska-Kiec A., Hartwich J., Lapicka-Bodzioch K., Banas A., Polus A., et al. The microarray expression analysis identifies BAX as a mediator of beta-carotene effects on apoptosis. Nutrition and Cancer 2005, 51:226-235.
29. Bonovas S., Filioussi K., Tsavaris N., Sitaras N.M. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials. Journal of Clinical Oncology 2006, 24:4808-4817.
30. Bonovas S., Nikolopoulos G., Filioussi K., Peponi E., Bagos P., Sitaras N.M. Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials. European Journal of Epidemiology 2010, 25:29-35.
31. Brozmanova J., Manikova D., Vlckova V., Chovanec M. Selenium: a double-edged sword for defense and offence in cancer. Archives of Toxicology 2010, 84:919-938.
32. Buckman S.Y., Gresham A., Hale P., Hruza G., Anast J., Masferrer J., Pentland A.P. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998, 19:723-729.
33. Burnett M.E., Wang S.Q. Current sunscreen controversies: a critical review. Photodermatology, Photoimmunology & Photomedicine 2011, 27:58-67.
34. Bush J.A., Cheung K.J., Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Experimental Cell Research 2001, 271:305-314.
35. Calamini B., Ratia K., Malkowski M.G., Cuendet M., Pezzuto J.M., Santarsiero B.D., et al. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochemical Journal 2010, 429:273-282.
36. Chen L.X., He Y.J., Zhao S.Z., Wu J.G., Wang J.T., Zhu L.M., et al. Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model. Cancer Biology & Therapy 2011, 11:229-235.
37. Cheung M., Sharma A., Madhunapantula S.V., Robertson G.P. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. Cancer Research 2008, 68:3429-3439.
38. Chung C.Y., Madhunapantula S.V., Desai D., Amin S., Robertson G.P. Melanoma prevention using topical PBISe. Cancer Prevention Research (Philadelphia, PA) 2011, 4:935-948.
39. Cichewicz R.H., Kouzi S.A. Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Medical Care Research and Review 2004, 24:90-114.
40. Clark L.C., Combs G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. The Journal of the American Medical Association 1996, 276:1957-1963.
41. Collisson E.A., Kleer C., Wu M., De A., Gambhir S.S., Merajver S.D., et al. Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells. Molecular Cancer Therapeutics 2003, 2:941-948.
42. Crampsie M.A., Jones N., Das A., Aliaga C., Desai D., Lazarus P., et al. Phenylbutyl isoselenocyanate modulates phase I and II enzymes and inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adducts in mice. Cancer Prevention Research (Philadelphia, PA) 2011, 4:1884-1894.
43. Croghan M.K., Booth A., Meyskens F.L. A phase I trial of recombinant interferon-alpha and alpha-difluoromethylornithine in metastatic melanoma. Journal of Biological Response Modifiers 1988, 7:409-415.
44. Curiel-Lewandrowski C., Nijsten T., Gomez M.L., Hollestein L.M., Atkins M.B., Stern R.S. Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. The Journal of Investigative Dermatology 2011, 131:1460-1468.
45. Dankort D., Curley D.P., Cartlidge R.A., Nelson B., Karnezis A.N., Damsky W.E., et al. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nature Genetics 2009, 41:544-552.
46. Demierre M.F. Consideration of statins for chemoprevention of cutaneous melanoma. Journal of Drugs in Dermatology 2005, 4:125-128.
47. Demierre M.F., Higgins P.D., Gruber S.B., Hawk E., Lippman S.M. Statins and cancer prevention. Nature Reviews Cancer 2005, 5:930-942.
48. Demierre M.F., Merlino G. Chemoprevention of melanoma. Current Oncology Reports 2004, 6:406-413.
49. Demierre M.F., Nathanson L. Chemoprevention of melanoma: an unexplored strategy. Journal of Clinical Oncology 2003, 21:158-165.
50. Demierre M.F., Sondak V.K. Chemoprevention of melanoma: theoretical and practical considerations. Cancer Control 2005, 12:219-222.
51. Demierre M.F., Sondak V.K. Cutaneous melanoma: pathogenesis and rationale for chemoprevention. Critical Reviews in Oncology/Hematology 2005, 53:225-239.
52. Denkert C., Kobel M., Berger S., Siegert A., Leclere A., Trefzer U., et al. Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Research 2001, 61:303-308.
53. Dennert G., Zwahlen M., Brinkman M., Vinceti M., Zeegers M.P., Horneber M. Selenium for preventing cancer. Cochrane Database of Systematic Reviews 2011, CD005195.
54. Dennert G., Zwahlen M., Brinkman M., Vinceti M., Zeegers M.P., Horneber M. Selenium for preventing cancer. Sao Paulo Medical Journal 2012, 130:67.
55. Dennis L.K., Beane Freeman L.E., VanBeek M.J. Sunscreen use and the risk for melanoma: a quantitative review. Annals of Internal Medicine 2003, 139:966-978.
56. Desai D., Madhunapantula S.V., Gowdahalli K., Sharma A., Chandagaludoreswamy R., El-Bayoumy K., et al. Synthesis and characterization of a novel iNOS/Akt inhibitor Se, Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe) against colon cancer. Bioorganic & Medicinal Chemistry Letters 2010, 20:2038-2043.
57. Drolet B.A., Connor M.J. Sunscreens and the prevention of ultraviolet radiation-induced skin cancer. The Journal of Dermatologic Surgery and Oncology 1992, 18:571-576.
58. Duffield-Lillico A.J., Reid M.E., Turnbull B.W., Combs G.F., Slate E.H., Fischbach L.A., et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the nutritional prevention of cancer trial. Cancer Epidemiology, Biomarkers & Prevention 2002, 11:630-639.
59. Duffield-Lillico A.J., Shureiqi I., Lippman S.M. Can selenium prevent colorectal cancer? A signpost from epidemiology. Journal of the National Cancer Institute 2004, 96:1645-1647.
60. Eisman J.A., Barkla D.H., Tutton P.J. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Research 1987, 47:21-25.
61. Ekmekcioglu S., Ellerhorst J.A., Prieto V.G., Johnson M.M., Broemeling L.D., Grimm E.A. Tumor iNOS predicts poor survival for stage III melanoma patients. International Journal of Cancer 2006, 119:861-866.
62. Elmets C.A., Viner J.L., Pentland A.P., Cantrell W., Lin H.Y., Bailey H., et al. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. Journal of the National Cancer Institute 2010, 102:1835-1844.
63. Feleszko W., Mlynarczuk I., Olszewska D., Jalili A., Grzela T., Lasek W., et al. Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism. International Journal of Cancer 2002, 100:111-118.
64. Fitzpatrick F.A. Cyclooxygenase enzymes: regulation and function. Current Pharmaceutical Design 2004, 10:577-588.
65. Flower R.J. The development of COX2 inhibitors. Nature Reviews. Drug Discovery 2003, 2:179-191.
66. Freedman A.N., Graubard B.I., Rao S.R., McCaskill-Stevens W., Ballard-Barbash R., Gail M.H. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. Journal of the National Cancer Institute 2003, 95:526-532.
67. Friedman E.S., LaNatra N., Stiller M.J. NSAIDs in dermatologic therapy: review and preview. Journal of Cutaneous Medicine and Surgery 2002, 6:449-459.
68. Frieling U.M., Schaumberg D.A., Kupper T.S., Muntwyler J., Hennekens C.H. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study. Archives of Dermatology 2000, 136:179-184.
69. Fulda S., Friesen C., Los M., Scaffidi C., Mier W., Benedict M., et al. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Research 1997, 57:4956-4964.
70. Galgon T., Wohlrab W., Drager B. Betulinic acid induces apoptosis in skin cancer cells and differentiation in normal human keratinocytes. Experimental Dermatology 2005, 14:736-743.
71. Goldenhersh M.A., Koslowsky M. Increased melanoma after regular sunscreen use?. Journal of Clinical Oncology 2011, 29:e557-558. author reply e859.
72. Gorham E.D., Mohr S.B., Garland C.F., Chaplin G., Garland F.C. Do sunscreens increase risk of melanoma in populations residing at higher latitudes?. Annals of Epidemiology 2007, 17:956-963.
73. Green A., Williams G., Neale R., Hart V., Leslie D., Parsons P., et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999, 354:723-729.
74. Green A.C., Williams G.M., Logan V., Strutton G.M. Reduced melanoma after regular sunscreen use: randomized trial follow-up. Journal of Clinical Oncology 2011, 29:257-263.
75. Gupta S., Mukhtar H. Chemoprevention of skin cancer through natural agents. Skin Pharmacology and Applied Skin Physiology 2001, 14:373-385.
76. Gupta S.C., Prasad S., Kim J.H., Patchva S., Webb L.J., Priyadarsini I.K., et al. Multitargeting by curcumin as revealed by molecular interaction studies. Natural Product Reports 2011, 28:1937-1955.
77. Guruvayoorappan C., Kuttan G. Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells. Integrative Cancer Therapies 2007, 6:258-270.
78. Ha L., Noonan F.P., De Fabo E.C., Merlino G. Animal models of melanoma. Journal of Investigative Dermatology Symposium Proceedings 2005, 10:86-88.
79. Heng M.C. Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy. International Journal of Dermatology 2010, 49:608-622.
80. Hippisley-Cox J., Coupland C. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. British Medical Journal 2010, 340:c2197.
81. Hocker T., Tsao H. Ultraviolet radiation and melanoma: s systematic review and analysis of reported sequence variants. Human Mutation 2007, 28:578-588.
82. Holly E.A., Aston D.A., Cress R.D., Ahn D.K., Kristiansen J.J. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. American Journal of Epidemiology 1995, 141:923-933.
83. Holly E.A., Aston D.A., Cress R.D., Ahn D.K., Kristiansen J.J. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. American Journal of Epidemiology 1995, 141:934-942.
84. Holly E.A., Cress R.D., Ahn D.K. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. American Journal of Epidemiology 1995, 141:943-950.
85. Holthoff J.H., Woodling K.A., Doerge D.R., Burns S.T., Hinson J.A., Mayeux P.R. Resveratrol, a dietary polyphenolic phytoalexin, is a functional scavenger of peroxynitrite. Biochemical Pharmacology 2010, 80:1260-1265.
86. Huang M.T., Ma W., Yen P., Xie J.G., Han J., Frenkel K., et al. Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis 1997, 18:83-88.
87. Huncharek M., Kupelnick B. Use of topical sunscreens and the risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case-control studies. American Journal of Public Health 2002, 92:1173-1177.
88. Husain Z., Pathak M.A., Flotte T., Wick M.M. Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7,12-dimethylbenz(a)anthracene application and ultraviolet irradiation. Cancer Research 1991, 51:4964-4970.
89. Jeter J.M., Bonner J.D., Johnson T.M., Gruber S.B. Nonsteroidal anti-inflammatory drugs and risk of melanoma. Journal of Skin Cancer 2011, 2011:598571.
90. Johnson G.E., Ivanov V.N., Hei T.K. Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis 2008, 13:790-802.
91. Joosse A., Koomen E.R., Casparie M.K., Herings R.M., Guchelaar H.J., Nijsten T. Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study. The Journal of Investigative Dermatology 2009, 129:2620-2627.
92. Jordan V.C. Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nature Reviews Cancer 2007, 7:46-53.
93. Kakar S.S., Roy D. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Letters 1994, 87:85-89.
94. Katiyar S.K. Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects (review). International Journal of Oncology 2005, 26:169-176.
95. Katiyar S., Elmets C.A., Katiyar S.K. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. Journal of Nutritional Biochemistry 2007, 18:287-296.
96. Katiyar S.K., Mantena S.K., Meeran S.M. Silymarin protects epidermal keratinocytes from ultraviolet radiation-induced apoptosis and DNA damage by nucleotide excision repair mechanism. PLoS One 2011, 6. e21410.
97. Khan Z., Khan N., Tiwari R.P., Sah N.K., Prasad G.B., Bisen P.S. Biology of Cox-2: an application in cancer therapeutics. Current Drug Targets 2011, 12:1082-1093.
98. Khosravi-Far R., Cox A.D., Kato K., Der C.J. Protein prenylation: key to ras function and cancer intervention?. Cell Growth & Differentiation 1992, 3:461-469.
99. Kidera Y., Tsubaki M., Yamazoe Y., Shoji K., Nakamura H., Ogaki M., et al. Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway. Journal of Experimental & Clinical Cancer Research 2010, 29:127.
100. Kim J.H., Gupta S.C., Park B., Yadav V.R., Aggarwal B.B. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-kappaB and NF-kappaB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Molecular Nutrition & Food Research 2011.
101. Kim K.H., Back J.H., Zhu Y., Arbesman J., Athar M., Kopelovich L., et al. Resveratrol targets transforming growth factor-beta2 signaling to block UV-induced tumor progression. The Journal of Investigative Dermatology 2011, 131:195-202.
102. Kim H.S., Kim M.J., Kim E.J., Yang Y., Lee M.S., Lim J.S. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochemical Pharmacology 2012, 83:385-394.
103. Klug H.L., Tooze J.A., Graff-Cherry C., Anver M.R., Noonan F.P., Fears T.R., et al. Sunscreen prevention of melanoma in man and mouse. Pigment Cell & Melanoma Research 2010, 23:835-837.
104. Konta L., Szaraz P., Magyar J.E., Revesz K., Banhegyi G., Mandl J., et al. Inhibition of glycoprotein synthesis in the endoplasmic reticulum as a novel anticancer mechanism of (-)-epigallocatechin-3-gallate. Biofactors 2011, 37:468-476.
105. Kubota S., Ohsawa N., Takaku F. Effects of DL-alpha-difluoromethylornithine on the growth and metastasis of B16 melanoma in vivo. International Journal of Cancer 1987, 39:244-247.
106. Kuoppala J., Lamminpaa A., Pukkala E. Statins and cancer: a systematic review and meta-analysis. European Journal of Cancer 2008, 44:2122-2132.
107. Langone P., Debata P.R., Dolai S., Curcio G.M., Inigo J.D., Raja K., et al. Coupling to a cancer cell-specific antibody potentiates tumoricidal properties of curcumin. International Journal of Cancer 2011.
108. Lao C.D., Demierre M.F., Sondak V.K. Targeting events in melanoma carcinogenesis for the prevention of melanoma. Expert Review of Anticancer Therapy 2006, 6:1559-1568.
109. Li D., Graef G.L., Yee J.A., Yan L. Dietary supplementation with high-selenium soy protein reduces pulmonary metastasis of melanoma cells in mice. The Journal of Nutrition 2004, 134:1536-1540.
110. Li L.H., Wu L.J., Zhou B., Wu Z., Tashiro S., Onodera S., et al. Silymarin prevents UV irradiation-induced A375-S2 cell apoptosis. Biological & Pharmaceutical Bulletin 2004, 27:1031-1036.
111. Li L.H., Wu L.J., Tashiro S.I., Onodera S., Uchiumi F., Ikejima T. The roles of Akt and MAPK family members in silymarin's protection against UV-induced A375-S2 cell apoptosis. International Immunopharmacology 2006, 6:190-197.
112. Limtrakul P., Lipigorngoson S., Namwong O., Apisariyakul A., Dunn F.W. Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Letters 1997, 116:197-203.
113. Limtrakul P., Anuchapreeda S., Lipigorngoson S., Dunn F.W. Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin. BMC Cancer 2001, 1:1.
114. Lippman S.M., Hong W.K. Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clinical Cancer Research, 8: 314-346. Clinical Cancer Research 2002, 8:305-313.
115. Lippman S.M., Hong W.K. Cancer prevention science and practice. Cancer Research 2002, 62:5119-5125.
116. Lippman S.M., Klein E.A., Goodman P.J., Lucia M.S., Thompson I.M., Ford L.G., et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Journal of the American Medical Association 2009, 301:39-51.
117. Liu J.D., Chen S.H., Lin C.L., Tsai S.H., Liang Y.C. Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice. Journal of Cellular Biochemistry 2001, 83:631-642.
118. Lluria-Prevatt M., Morreale J., Gregus J., Alberts D.S., Kaper F., Giaccia A., et al. Effects of perillyl alcohol on melanoma in the TPras mouse model. Cancer Epidemiology, Biomarkers & Prevention 2002, 11:573-579.
119. Loden M., Beitner H., Gonzalez H., Edstrom D.W., Akerstrom U., Austad J., et al. Sunscreen use: controversies, challenges and regulatory aspects. British Journal of Dermatology 2011, 165:255-262.
120. Lu Y.P., Lou Y.R., Xie J.G., Peng Q.Y., Liao J., Yang C.S., et al. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:12455-12460.
121. Lund L.P., Timmins G.S. Melanoma, long wavelength ultraviolet and sunscreens: controversies and potential resolutions. Pharmacology & Therapeutics 2007, 114:198-207.
122. Madhunapantula S.V., Desai D., Sharma A., Huh S., Amin S., Robertson G.P. PBIse, a novel selenium containing drug for the treatment of malignant melanoma. Molecular Cancer Therapeutics 2008, 7:1297-1308.
123. Madhunapantula S.V., Robertson G.P. Therapeutic implications of targeting AKT signaling in melanoma. Enzyme Research 2011, 2011. 327923.
124. Manoharan S., Singh R.B., Balakrishnan S. Chemopreventive mechanisms of natural products in oral, mammary and skin carcinogenesis: an overview. The Open Nutraceuticals Journal 2009, 2:52-63.
125. Marin Y.E., Wall B.A., Wang S., Namkoong J., Martino J.J., Suh J., et al. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Research 2007, 17:274-283.
126. Meeran S.M., Katiyar S., Elmets C.A., Katiyar S.K. Silymarin inhibits UV radiation-induced immunosuppression through augmentation of interleukin-12 in mice. Molecular Cancer Therapeutics 2006, 5:1660-1668.
127. Menon L.G., Kuttan R., Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Letters 1995, 95:221-225.
128. Meyskens F.L., Kingsley E.M., Glattke T., Loescher L., Booth A. A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma. Investigational New Drugs 1986, 4:257-262.
129. Miksits M., Wlcek K., Svoboda M., Kunert O., Haslinger E., Thalhammer T., et al. Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells. Planta Medica 2009, 75:1227-1230.
130. Millen A.E., Tucker M.A., Hartge P., Halpern A., Elder D.E., Guerry D., et al. Diet and melanoma in a case-control study. Cancer Epidemiology, Biomarkers & Prevention 2004, 13:1042-1051.
131. Mimeault M., Batra S.K. Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chinese Medicine 2011, 6:31.
132. Ming M.E. The search for a chemoprevention agent effective against melanoma: considerations and challenges. The Journal of Investigative Dermatology 2011, 131:1401-1403.
133. Mintz B., Silvers W.K. Transgenic mouse model of malignant skin melanoma. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:8817-8821.
134. Mittal A., Piyathilake C., Hara Y., Katiyar S.K. Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia 2003, 5:555-565.
135. Mullauer F.B., Kessler J.H., Medema J.P. Betulinic acid, a natural compound with potent anticancer effects. Anticancer Drugs 2010, 21:215-227.
136. Nambiar D., Rajamani P., Singh R.P. Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy. Mutation Research 2011, 728:139-157.
137. Naylor M.F., Boyd A., Smith D.W., Cameron G.S., Hubbard D., Neldner K.H. High sun protection factor sunscreens in the suppression of actinic neoplasia. Archives of Dermatology 1995, 131:170-175.
138. Nguyen N., Sharma A., Nguyen N., Sharma A.K., Desai D., Huh S.J., et al. Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. Cancer Prevention Research (Philadelphia, PA) 2011, 4:248-258.
139. Nguyen N., Sharma A., Sharma A.K., Desai D., Huh S.J., Amin S., et al. Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4. Cancer Prevention Research (Philadelphia, PA) 2011, 4:248-258.
140. Nichols J.A., Katiyar S.K. Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Archives of Dermatology Research 2010, 302:71-83.
141. Nihal M., Ahmad N., Mukhtar H., Wood G.S. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: Possible implications for the chemoprevention of melanoma. International Journal of Cancer 2005, 114:513-521.
142. Niles R.M., Cook C.P., Meadows G.G., Fu Y.M., McLaughlin J.L., Rankin G.O. Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth. The Journal of Nutrition 2006, 136:2542-2546.
143. Niles R.M., McFarland M., Weimer M.B., Redkar A., Fu Y.M., Meadows G.G. Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Letters 2003, 190:157-163.
144. Noonan F.P., Dudek J., Merlino G., De Fabo E.C. Animal models of melanoma: an HGF/SF transgenic mouse model may facilitate experimental access to UV initiating events. Pigment Cell Research 2003, 16:16-25.
145. Park I.S., Jo J.R., Hong H., Nam K.Y., Kim J.B., Hwang S.H., et al. Aspirin induces apoptosis in YD-8 human oral squamous carcinoma cells through activation of caspases, down-regulation of Mcl-1, and inactivation of ERK-1/2 and AKT. Toxicology In Vitro 2010, 24:713-720.
146. Patel K.R., Scott E., Brown V.A., Gescher A.J., Steward W.P., Brown K. Clinical trials of resveratrol. Annals of the New York Academy of Sciences 2011, 1215:161-169.
147. Pathak M.A. Ultraviolet radiation and the development of non-melanoma and melanoma skin cancer: clinical and experimental evidence. Skin Pharmacology 1991, 4(Suppl. 1):85-94.
148. Paulitschke V., Schicher N., Szekeres T., Jager W., Elbling L., Riemer A.B., et al. 3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model. The Journal of Investigative Dermatology 2010, 130:1668-1679.
149. Pisha E., Chai H., Lee I.S., Chagwedera T.E., Farnsworth N.R., Cordell G.A., et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nature Medicine 1995, 1:1046-1051.
150. Planta M.B. Sunscreen and melanoma: is our prevention message correct?. The Journal of the American Board of Family Medicine 2011, 24:735-739.
151. Qiu L., Wang Q., Di W., Jiang Q., Schefeller E., Derby S., et al. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. International Journal of Oncology 2005, 27:823-830.
152. Quinn A.G. Ultraviolet radiation and skin carcinogenesis. British Journal of Hospital Medicine 1997, 58:261-264.
153. Rajendran P., Ho E., Williams D.E., Dashwood R.H. Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clinical Epigenetics 2011, 3:4.
154. Ray S., Chattopadhyay N., Mitra A., Siddiqi M., Chatterjee A. Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. Journal of Environmental Pathology, Toxicology and Oncology 2003, 22:49-58.
155. Reichrath J., Rech M., Moeini M., Meese E., Tilgen W., Seifert M. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells. Cancer Biology & Therapy 2007, 6:48-55.
156. Rieber M., Rieber M.S. Signalling responses linked to betulinic acid-induced apoptosis are antagonized by MEK inhibitor U0126 in adherent or 3D spheroid melanoma irrespective of p53 status. International Journal of Cancer 2006, 118:1135-1143.
157. Rieber M., Strasberg Rieber M. Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma. DNA and Cell Biology 1998, 17:399-406.
158. Rieber M., Strasberg-Rieber M. Induction of p53 and melanoma cell death is reciprocal with down-regulation of E2F, cyclin D1 and pRB. International Journal of Cancer 1998, 76:757-760.
159. Robertson G.P. Functional and therapeutic significance of Akt deregulation in malignant melanoma. Cancer Metastasis Reviews 2005, 24:273-285.
160. Rothwell P.M., Wilson M., Elwin C.E., Norrving B., Algra A., Warlow C.P., et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010, 376:1741-1750.
161. Rothwell P.M., Price J.F., Fowkes F.G., Zanchetti A., Roncaglioni M.C., Tognoni G., et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012.
162. Rothwell P.M., Wilson M., Price J.F., Belch J.F., Meade T.W., Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 2012.
163. Rundhaug J.E., Fischer S.M. Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochemistry and Photobiology 2008, 84:322-329.
164. Sa G., Das T. Anti cancer effects of curcumin: cycle of life and death. Cell Division 2008, 3:14.
165. Satyamoorthy K., Meier F., Hsu M.Y., Berking C., Herlyn M. Human xenografts, human skin and skin reconstructs for studies in melanoma development and progression. Cancer Metastasis Reviews 1999, 18:401-405.
166. Sharma A.K., Sharma A., Desai D., Madhunapantula S.V., Huh S.J., Robertson G.P., et al. Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates. Journal of Medicinal Chemistry 2008, 51:7820-7826.
167. Sharma A., Sharma A.K., Madhunapantula S.V., Desai D., Huh S.J., Mosca P., et al. Targeting Akt3 signaling in malignant melanoma using isoselenocyanates. Clinical Cancer Research 2009.
168. Sharma A.K., Kline C.L., Berg A., Amin S., Irby R.B. The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model. Clinical Cancer Research 2011, 17:4474-4483.
169. Sikora A.G., Gelbard A., Davies M.A., Sano D., Ekmekcioglu S., Kwon J., et al. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Clinical Cancer Research 2010, 16:1834-1844.
170. Siwak D.R., Shishodia S., Aggarwal B.B., Kurzrock R. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 2005, 104:879-890.
171. Sporn M.B., Dunlop N.M., Newton D.L., Henderson W.R. Relationships between structure and activity of retinoids. Nature 1976, 263:110-113.
172. Sporn M.B., Dunlop N.M., Newton D.L., Smith J.M. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Federation Proceedings 1976, 35:1332-1338.
173. Stahl J.M., Sharma A., Cheung M., Zimmerman M., Cheng J.Q., Bosenberg M.W., et al. Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Research 2004, 64:7002-7010.
174. Stahl W., Sies H. Photoprotection by dietary carotenoids: concept, mechanisms, evidence and future development. Molecular Nutrition & Food Research 2011.
175. Struh C.M., Jager S., Schempp C.M., Scheffler A., Martin S.F. A novel triterpene extract from mistletoe induces rapid apoptosis in murine B16.F10 melanoma cells. Phytotherapy Research 2012.
176. Sunkara P.S., Prakash N.J., Rosenberger A.L., Hagan A.C., Lachmann P.J., Mayer G.D. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers. Cancer Research 1984, 44:2799-2802.
177. Sunkara P.S., Bowlin T.L., Rosenberger A.L., Fleischmann W.R. Effect of murine alpha-, beta-, and gamma-interferons in combination with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on the tumor growth and metastasis of B16 melanoma and Lewis lung carcinoma in mice. Journal of Biological Response Modifiers 1989, 8:170-179.
178. Sunkara P.S., Rosenberger A.L. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice. Cancer Research 1987, 47:933-935.
179. Surowiak P., Drag M., Materna V., Dietel M., Lage H. Betulinic acid exhibits stronger cytotoxic activity on the normal melanocyte NHEM-neo cell line than on drug-resistant and drug-sensitive MeWo melanoma cell lines. Molecular Medicine Reports 2009, 2:543-548.
180. Szekeres T., Fritzer-Szekeres M., Saiko P., Jager W. Resveratrol and resveratrol analogues-structure-activity relationship. Pharmaceutical Research 2010, 27:1042-1048.
181. Szekeres T., Saiko P., Fritzer-Szekeres M., Djavan B., Jager W. Chemopreventive effects of resveratrol and resveratrol derivatives. Annals of the New York Academy of Sciences 2011, 1215:89-95.
182. Tanaka T., Kohno H., Murakami M., Kagami S., El-Bayoumy K. Suppressing effects of dietary supplementation of the organoselenium 1,4-phenylenebis(methylene)selenocyanate and the Citrus antioxidant auraptene on lung metastasis of melanoma cells in mice. Cancer Research 2000, 60:3713-3716.
183. Taniguchi S., Fujiki H., Kobayashi H., Go H., Miyado K., Sadano H., et al. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Letters 1992, 65:51-54.
184. Vaid M., Katiyar S.K. Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (review). International Journal of Oncology 2010, 36:1053-1060.
185. Vaid M., Prasad R., Sun Q., Katiyar S.K. Silymarin targets beta-catenin signaling in blocking migration/invasion of human melanoma cells. PLoS One 2011, 6:e23000.
186. van der Pols J.C., Williams G.M., Pandeya N., Logan V., Green A.C. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiology, Biomarkers & Prevention 2006, 15:2546-2548.
187. Walker G. Cutaneous melanoma: how does ultraviolet light contribute to melanocyte transformation?. Future Oncology 2008, 4:841-856.
188. Walle T. Bioavailability of resveratrol. Annals of the New York Academy of Sciences 2011, 1215:9-15.
189. Walter R.B., Kazianis S. Xiphophorus interspecies hybrids as genetic models of induced neoplasia. ILAR Journal 2001, 42:299-321.
190. Wang H.T., Choi B., Tang M.S. Melanocytes are deficient in repair of oxidative DNA damage and UV-induced photoproducts. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:12180-12185.
191. Weinberg J.M. Topical therapy for actinic keratoses: current and evolving therapies. Reviews on Recent Clinical Trials 2006, 1:53-60.
192. Weinstock M.A. Do sunscreens increase or decrease melanoma risk: an epidemiologic evaluation. Journal of Investigative Dermatology Symposium Proceedings 1999, 4:97-100.
193. Weinstock M.A., Stampfer M.J., Lew R.A., Willett W.C., Sober A.J. Case-control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use. The Journal of Investigative Dermatology 1992, 98:809-811.
194. Wilgus T.A., Breza T.S., Tober K.L., Oberyszyn T.M. Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors. The Journal of Investigative Dermatology 2004, 122:1488-1494.
195. Wilson K.S. Clinical activity of celecoxib in metastatic malignant melanoma. Cancer Investigation 2006, 24:740-746.
196. Wilson K.S. Cyclooxygenase-2 inhibition and regression of metastatic melanoma. Melanoma Research 2006, 16:465.
197. Wolf P., Donawho C.K., Kripke M.L. Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice. Journal of the National Cancer Institute 1994, 86:99-105.
198. Yan L., Yee J.A., Li D., McGuire M.H., Graef G.L. Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice. Anticancer Research 1999, 19:1337-1342.
199. Zhou X.M., Wong B.C., Fan X.M., Zhang H.B., Lin M.C., Kung H.F., et al. Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis 2001, 22:1393-1397.